Sensor augmented pump therapy with predictive suspension function for low glucose levels reduces time in hypoglycaemia in pregnant women with type 1 diabetes
- PMID: 37191717
- DOI: 10.1007/s00592-023-02080-5
Sensor augmented pump therapy with predictive suspension function for low glucose levels reduces time in hypoglycaemia in pregnant women with type 1 diabetes
References
-
- Battelino T, Danne T, Bergenstal RM et al (2019) Clinical targets for continuous glucose monitoring data interpretation: recommendations from the international consensus on time in range. Diabetes Care 42(8):1593–1603. https://doi.org/10.2337/dci19-0028 - DOI - PubMed - PMC
-
- Farrar D, Tuffnell DJ, West J, West HM (2016) Continuous subcutaneous insulin infusion versus multiple daily injections of insulin for pregnant women with diabetes. Cochrane Database Syst Rev 6:CD005542. https://doi.org/10.1002/14651858.CD005542.pub3 - DOI
-
- Feig DS, Donovan LE, Corcoy R et al (2017) Continuous glucose monitoring in pregnant women with type 1 diabetes (CONCEPTT): a multicentre international randomised controlled trial. Lancet 390(10110):2347–2359. https://doi.org/10.1016/S0140-6736(17)32400-5 - DOI - PubMed - PMC
-
- Forlenza GP, Li Z, Buckingham BA et al (2018) Predictive low-glucose suspend reduces hypoglycemia in adults, adolescents, and children with type 1 diabetes in an at-home randomized crossover study: results of the PROLOG trial. Diabetes Care 41(10):2155–2161. https://doi.org/10.2337/dc18-0771 - DOI - PubMed
-
- Feig DS, Corcoy R, Donovan LE et al (2018) Pumps or multiple daily injections in pregnancy involving type 1 diabetes: a prespecified analysis of the CONCEPTT randomized trial. Diabetes Care 41(12):2471–2479. https://doi.org/10.2337/dc18-1437 - DOI - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical